Author

Ray J. Unwalla

Pfizer (United States)ORCID 0000-0002-5789-7336Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Research Focus:protein structure prediction· 1 Assay:structural biology· 1

Frequent Co-Authors

Alpay Dermenci· 1 shared Andrew C. FlickiD· 1 shared Atli ThorarenseniD· 1 shared Barbara J. HoganiD· 1 shared Brian S. GerstenbergeriD· 1 shared Christine Oswald· 1 shared Chulho ChoiiD· 1 shared Daniel Lamb· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Alpay Dermenci

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Structural basis for CCR6 modulation by allosteric antagonists

David Jon Wasilko, Brian S. Gerstenberger, Kathleen A. Farley, Wěi Li, Jennifer Alley, Mark E. Schnute, Ray J. Unwalla, Jorge Victorino, Kimberly K. Crouse, Ru Ding, Parag V. Sahasrabudhe, Fabien Vincent, Richard K. Frisbie, Alpay Dermenci, Andrew C. Flick, , Huixian Wu

This paper presents two inactive CCR6 structures bound to allosteric antagonists, revealing structural insights into CCR6 inhibition and its implications for drug discovery.

Nature Communications · Aug 31, 2024Peer-reviewedBiochemistry